This inventor holds 6 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1992-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-1994
Title: Thomas M Zydowsky: Innovator in Pharmaceutical Chemistry
Introduction
Thomas M Zydowsky is a notable inventor based in Waukegan, Illinois. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of angiotensin II receptor antagonists. With a total of six patents to his name, Zydowsky's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents, Zydowsky has developed compounds that serve as angiotensin II receptor antagonists. These compounds are characterized by a specific formula, wherein the substituents are defined in detail. Additionally, he has disclosed a process for the preparation of a renin inhibiting compound. This process involves intermediates that are useful for creating a compound with a defined formula, which includes various nitrogen-containing heterocycles and other substituents.
Career Highlights
Zydowsky is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in drug development and therapeutic applications. His expertise in pharmaceutical chemistry has positioned him as a key player in the industry.
Collaborations
Throughout his career, Zydowsky has collaborated with esteemed colleagues such as Biswanath De and Martin Winn. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical research.
Conclusion
Thomas M Zydowsky's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
